Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells
Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells
复制标题
常见急性淋巴细胞白血病抗原 (CD10) 作为成熟人类 B 细胞激活分子的表征
DOI:
--
复制
发表时间:
1990
影响因子:
4.6
通讯作者:
J. Hata
中科院分区:
文献类型:
--
作者:
N. Kiyokawa;Y. Kokai;K. Ishimoto;H. Fujita;J. Fujimoto;J. Hata
Distinct expression pattern of CD10 molecules during B cell activation was analysed using in vivo and in vitro systems. By two‐colour flowcytometrical analysis, CD10 was found to be expressed at a specificstage of in vivo activating B cells. The expression of CD10 during B cell activation appeared to be unique from that of other activation‐related B cell antigens including L29, MA6, OKT9 and OKT10. Although the expression of CD10 was associated with that of the activation‐related B cell antigens, CD 10+ B cells could be separated in the distinct fractions to those expressing other activation‐related B cell antigens when fractionated by cell gravity. In particular, certain CD10+ B cells were detected positive for the resting B cell antigen, L30. In vitro studies revealed that CD10+ B cells arose from CD10‐ B cells at an early step of B cell activation, and disappeared lately when activated by Staphylococcus aureus Cowan I. Collectively, CD10 was an antigen transiently expressed at an early phase of B cell activation process. Expression of CD10 and other antigens on Burkitt's lymphomas (15 cases) was studied next. All cases were CD10+, and 87% (13 cases) were also L30+. In addition, six of CD10+ L30+ cases were L29+. This observation suggested that Burkitt's lymphomas were phenotypically similar to the B cells at an early phase of activation, those expressing CD10 and L30, simultaneously. The present study has dissected a precise expression pattern of CD10 on mature B cell activation in vitro and in vivo, and could be implicated for the histogenesis of one of the poorly characterized B cell lymphoma, namely Burkitt's lymphoma.
登录
查看更多内容
影响因子:
20.3
作者:
M. Loken;V. O. Shah;Karen L. Dattilio;C. Civin
通讯作者:
M. Loken;V. O. Shah;Karen L. Dattilio;C. Civin
影响因子:
20.3
作者:
Ryan,D;Kossover,S;Mitchell,S;Frantz,C;Hennessy,L;Cohen,H
通讯作者:
Cohen,H
DOI:
10.1016/0090-1229(81)90193-8
发表时间:
1981
期刊:
Clinical immunology and immunopathology
影响因子:
--
作者:
Dagg,MK;Levitt,D
通讯作者:
Levitt,D
影响因子:
20.3
作者:
Hokland,P;Nadler,LM;Griffin,JD;Schlossman,SF;Ritz,J
通讯作者:
Ritz,J
DOI:
--
发表时间:
1985
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Freedman,AS;Boyd,AW;Anderson,KC;Fisher,DC;Schlossman,SF;Nadler,LM
通讯作者:
Nadler,LM